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Over the past decade a trend of increasing estimated
glomerular filtration rate (eGFR) at the initiation of dialysis
for treatment of end-stage renal disease (ESRD) has been
noted in the United States. In 1996, only 19% of patients
began dialysis therapy with an eGFR of greater than
10 ml/min/1.73m2 (denoted as ‘early start’), but by 2005 the
fraction of early start dialysis patients had risen to 45%. This
review examines US dialysis data, national guidelines, and
publications relevant to the early start phenomenon. It
is not known whether early start of dialysis is beneficial,
harmful or neutral with respect to the outcome of dialysis
treatment for ESRD. Available data indicate that mortality
while on dialysis therapy may be higher in those subjects
with early start. Comorbidities present at the time of dialysis
initiation do not appear to be a major driving force for early
start patients. As well, residual kidney function in these
patients is a major contributor to total urea or creatinine
clearance. This can be a positive factor for patient
outcomes and might be compromised by early start.
Finally, we estimate the dollar cost of early start to the
US Medicare-supported ESRD program. Properly designed,
prospective and randomized studies may help to clarify the
benefit or harm of early start of dialysis for ESRD.
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The purpose of this Mini-Review is to describe and analyze a
recent phenomenon; namely, the decline in average serum
creatinine levels (which translates to an increase in the
calculated estimated glomerular filtration rate (eGFR)) at the
initiation of dialysis in the USA in the preceding decade.
Using standard analysis files from the United States Renal
Data System (USRDS), we examined trends in eGFR at
initiation of dialysis and found a dramatic increase in the
frequency of patients initiating dialysis (both hemodialysis
and peritoneal dialysis) with estimated eGFRs above 10 ml/
min per 1.73 m2, herein denoted as ‘early start’ of dialysis1
(see Figure 1). In 1996 15% of patients initiated dialysis with
an eGFR of 10–14.9 ml/min per 1.73 m2 and only 4% started
dialysis with eGFR greater than 15 ml/min per 1.73 m2. Ten
years later, in 2005, 30% of patients started dialysis at eGFR
values of 10–14.9 ml/min and 15% started dialysis with eGFR
values greater than 15 ml/min per 1.73 m2. The frequency of
eGFR X10 ml/min per 1.73 m2 rose to 54% in 2005 from
25% in 1996 in those patients over the age of 75 years at the
time of initiation of dialysis. In both 1996 and 2005, there
was a gradual increasing trend to initiate dialysis at higher
levels of eGFR with age, in adults ages 20 to over 75 years of
age (Figure 2), but this relationship became steeper in 2005.
Similar observations have been reported by Kurella et al.2, in
2007 in octogenarians and nonagenarians. A very large
fraction of the rise in the incident dialysis frequency over the
period 1996–2005 can be attributed to an early start (see
Figure 1).
These observations generate several important questions:
(1) what are the potential impacts of this change in practice
on the subsequent mortality and/or morbidity of dialysis
therapy? (2) What factors have driven the change in the
frequency of early start of dialysis and (3) what are the
implications of these observations on the reported incidence
of patients newly treated with dialysis and the attendant
expense to the Medicare-ESRD program?
WHAT ARE THE IMPACTS OF ‘EARLY START’ ON DIALYSIS
OUTCOMES?
The timing of initiation of dialysis for ESRD is a matter of
clinical judgment guided by values of residual kidney
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function (RKF) and symptoms and signs present in the
patients, including those related to comorbidity. In 1999
Obrador et al.3, observed that 23% of the US ESRD
population, between 1995 and 1997, started dialysis at an
eGFR less than 5 ml/min per 1.73 m2. They opined that this
‘late start’ of dialysis needed further examination, including
studies of the impact on outcomes and cost of ESRD
treatment. In 1997 the National Kidney Foundation (NKF)
workgroup, after a comprehensive review of the published
literature, recommended that initiation of dialysis be
considered when the arithmetic mean of the urea and
creatinine clearances fell below approximately 10.5 ml/min
per 1.73 m2 except in well-nourished, asymptomatic pa-
tients.4 One of the early studies used to support this
recommendation was the CANUSA study of continuous
ambulatory peritoneal dialysis, an observational study that
suggested a potential benefit on renal survival of a weekly
peritoneal creatinine clearance of 470 l/1.73 m2.5 This would
correspond to an RKF measured by creatinine clearance of
about 9–14 ml/min per 1.73 m2.6 Subsequent studies, includ-
ing the ADEMEX randomized control trial, led to doubt
regarding the appropriateness of using of peritoneal clear-
ances of creatinine for guiding the timing of initiation of
dialysis.7 Similar conclusions were reached in the HEMO trial
of hemodialysis therapy.8 Both the ADEMEX and HEMO
trials demonstrated that higher levels of removal of urea or
creatinine by dialysis do not necessarily translate into better
outcomes. In addition, although the CANUSA study
supported a relationship between the level of peritoneal
clearance and survival, one can argue that the RKF in these
continuous ambulatory peritoneal dialysis patients was
primarily responsible for the survival advantage. Further-
more, it is difficult to understand why, in patients with a RKF
roughly equivalent to a weekly peritoneal urea clearance of
70 l per min, thus double the minimal peritoneal clearance
suggested by CANUSA, the NKF guideline for RKF at the
start of dialysis was promulgated.
In 2006, the NKF work group updated the guidelines
for initiation of hemodialysis and stated that ‘at CKD Stage 5,
when the eGFR is o15 ml/min per 1.73 m2, that nephrolo-
gists should evaluate the benefits, risks and disadvantages of
beginning renal replacement therapy’.9 They also suggested
that initiation of dialysis therapy before CKD Stage 5 (an
eGFR of 415 ml/min per 1.73 m2) may be appropriate in
patients who have symptoms believed to be related to both
their comorbidities and their level of RKF. The NKF
workgroup also opined that the outcome data relating the
intensity of dialysis therapy (measured as Kt/V urea or
creatinine clearance) to improved outcomes, provided a
justification for the use of similar values of eGFR as
guidelines for the initiation of dialysis therapy despite results
to the contrary of the two available randomized controlled
trials addressing this issue.7,8 Nevertheless it should be
pointed out that existing guidelines do not advocate a
dialysis start point at a specific eGFR or serum creatinine
level, which some nephrologists may be undertaking due to a
misinterpretation of the NKF guidelines.
Additional published studies have not been able to
demonstrate any clear-cut benefits for early start of dialysis.
Studies by Bonomini, et al.10, led to a recommendation for
early start but did not account for ‘lead-time bias’ (that is,
not basing survival analysis on the same starting point of
RKF in patients who started early or late on dialysis) or
comorbidity. Churchill et al.6, in 1997, examined the
available studies to date dealing with the issue of dialysis
start time. These authors acknowledged the confounding
factors, including referral time bias, comorbidity, patient
compliance, and recommended a randomized controlled trial
to produce a definitive answer. Nevertheless, these authors
supported the initiation of dialysis at a creatinine clearance of
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Figure 1 | Incidence counts by eGFR: 1996 and 2005: All ages.
Number of adult (age greater than or equal to 20) incident cases
of ESRD in the United States by estimated glomerular filtration
rate (eGFR) for calendar years 1996 and 2005. eGFR is calculated
from the serum creatinine value reported on the CMS 2728
Medical Evidence form using the four-variable MDRD
(Modification of Diet in Renal Disease) Study equation.
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Figure 2 | Proportion starting dialysis at: X10 ml/min per
1.73 m2. Percentage of adult (age greater than or equal to 20)
incident cases of ESRD in the United States with eGFR greater
than or equal to 10 ml/min per 1.73 m2 by age group at the time
of their of dialysis initiation.
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9–14 ml/min, ‘if there is any clinical or laboratory evidence of
malnutrition’. They also suggested ‘the patient should be
informed of the controversy regarding timing of initiation of
dialysis’. Korevaar et al.11, in a rigorously conducted but
observational study, showed no advantage of early initiation
of dialysis after adjusting for lead-time bias. Traynor, et al.12,
in a European observational study, reported increased
mortality in patients who were initiated early on dialysis.
Kazmi et al.13, evaluated the effect of comorbidity and found
that initiation of dialysis at an eGFR of 410 ml/min per
1.73m2 versus an eGFR of o5 ml/min per 1.73m2 was
associated with a 42% increased mortality after adjusting for
all co-variates. Beddhu et al.14, using a large national random
sample of the US dialysis population, reported that with each
5 ml/min per 1.73m2 increase in the eGFR at initiation of
dialysis there was an increased hazard of death using a
multivariate (covariate adjusted) Cox model. Beddhu, et al.14
in a related study also noted that a lower serum creatinine
level (and thereby an increase in eGFR) could be a feature of
‘somatic’ malnutrition and reflect a change in body
composition (a reduction in muscle mass and curtailment
of endogenous creatinine production).15 Such patients may
have elevated, normal, or low body mass index, reflecting the
percentage of body fat. Patients with low muscle mass have
higher comorbidity burdens and a higher risk of all-cause and
cardiovascular mortality on dialysis therapy. The inference is
that a higher calculated eGFR (lower serum creatinine) at
initiation of dialysis might be a reflection of lower muscle mass.
Calculated eGFR values in this circumstance would over-
estimate the true RKF. Such somatic ‘malnutrition’ would be an
explanation for an inverse relationship between the serum
creatinine level at initiation and subsequent mortality risk.16
Our analysis of the most recent USRDS data shows a
higher mortality risk with higher eGFR start times.1 Patients
ages 65–74 years with an eGFR of 5–9.9 ml/min per 1.73 m2 at
the initiation of dialysis have a 25% first year mortality rate
and similarly aged patients with an eGFR of 415 ml/min per
1.73 m2 at initiation of dialysis have a 41.5% first year
mortality. Also noteworthy is that the eGFR at the time of
dialysis initiation has steadily increased in patients both with
and without extensive comorbidities at the time dialysis was
initiated between 1996 and 2005. This would be difficult to
attribute to a systematic rise in the prevalence of somatic
malnutrition at the time of initiation of dialysis over this
interval. In our analysis of the 1996–2005 USRDS data from
the medical evidence form, in over 900,000 patients, the
effect of increasing eGFR at the time of initiation of dialysis
on increased mortality remains even after adjustment of
variables including age, sex, race, and comorbid conditions
(including diabetes). Similar observations were reported in
two previous studies in the United States and one in the
United Kingdom. These studies found direct relationships
between eGFR or estimated creatinine clearances (both serum
creatinine level based) at the initiation of dialysis and
subsequent mortality that remained after correction for
demographic and all known comorbidity differences.12–14
Kurella et al.2, when comparing octogenarian and
nonagenarians, starting dialysis in 1996 versus 2003 noted
the latter group had a higher eGFR at initiation and less
comorbidity, but no difference in 1 year survival. Murtagh
et al.17, in a retrospective survival analysis of CKD 5 patients
over 75 years of age, found no difference in comorbidity
between patients treated with dialysis versus non-dialytic,
nephrologist care. These data tend to suggest that early start
is not being driven by a rise in the fraction of patients starting
dialysis with extensive comorbidities, as will be discussed
below.
WHAT ARE THE DRIVERS OF THE INCREASED FREQUENCY OF
EARLY START?
As the available data are largely observational; they are not
conclusive as to mechanisms underlying the early start of
dialysis and subsequent outcomes. Several non-mutually
exclusive hypotheses may be offered as possible explanations
for the secular trend in early start (as defined herein). These
include: (1) Too heavy reliance on eGFR values instead of
symptoms and signs of uremia for determining the optimal
time for initiation of dialysis; (2) a general lack of under-
standing by Nephrologists concerning the guidelines for the
use of eGFR or creatinine clearance values as one part of the
process for determining the ‘best’ time to initiate dialysis; (3)
Relative ease of management of renal failure related issues
(fluid overload, hypertension, uremic bone disease, anemia)
with dialysis therapy compared with customary conservative
outpatient care; (4) preemptive dialysis, especially in patients
with perceived uremia-related weight loss, anorexia and
manifestations of possible malnutrition (for example, hypo-
albuminemia); (5) financial motives to initiate dialysis early.
With respect to the latter hypothesis, similar secular trends in
eGFR at initiation of dialysis between 1997 and 2006 (43%
increase in mean eGFR at dialysis initiation) have been noted
in the United Kingdom, a country where financial incentives
favoring early start would seem to be lacking due to the low
penetrance of for-profit dialysis units and the lack of financial
benefit to the treating physician (UK Renal Registry Report
2006: http://www.renalreg.com/downloads/publications/). In
addition, financial incentives for early start of dialysis were
not different in the USA during the 10-year interval of our
study. Finally, according to our analysis of the USRDS data,
for-profit outpatient dialysis facilities have very similar eGFR
at start of dialysis versus not-for-profit outpatient dialysis
facilities during the 1995–2006 interval. A small rise in the
fraction of incident ESRD due to diabetes (43% in 1996 and
44.2% in 2005), does not account for the rise in the frequency
of early start over the time periods examined. At the present
time, it is not possible to determine, with any degree of cer-
tainty the most likely mechanisms underlying the observed
secular trends in eGFR at the time of starting dialysis. In
addition, to date, no randomized controlled trials of the
impact of timing of initiation of dialysis on subsequent
outcome have been published. The IDEAL randomized
controlled trials, which is in progress, may help clarify this
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uncertainty and provide useful data on the relationship
of timing of initiation of dialysis and survival, morbidity,
quality of life and costs of dialysis therapy.18
CAN EARLY START BE HARMFUL?
Collectively, the observations concerning a rise in the
frequency of early start prompts the need to consider the
potential harms of early start of dialysis because conclusive
evidence of a clear benefit is lacking. The NKF workgroup in
their 2006 update emphasized the importance of preservation
of RKF as prospective randomized trials and observational
studies have confirmed the importance of RKF in patients
undergoing dialysis therapy.7 The dose of dialysis received
may affect the outcome in patients without any RKF, but may
have less of an impact on outcome in those with substantial
RKF. The CANUSA study showed a strong association
between RKF at the start of dialysis and better nutritional
status.5 O’Hare et al.19, in a study of the US Veterans patients
with CKD class 3–5, 47% of whom were over 75, found that
RKF declined more slowly in the elderly versus younger
cohort. In addition, these authors demonstrated the im-
portant point that patients over 75 with CKD 4 (eGFR
15–29 ml/min per 1.73 m2) were far more likely to die than to
develop ESRD. Thus, preemptive start of hemodialysis,
especially in the elderly with significant levels of RKF, may
be detrimental because loss of eGFR may accelerate after
initiation of dialysis.20 In addition, according to current
guidelines, many of these elderly patients with stable CKD 4
may be subject to inappropriate vascular access procedures,
often repeated, with their accompanying post operative
complications, including serious infection. Hemodialysis
therapy is not innocuous and patients with adequate urine
output, often associated with higher levels of RKF may be
prone to intra-dialytic hypotension. For example, Termor-
shuizen, et al.21, in the Netherlands Cooperative Study on the
adequacy of dialysis, a large prospective, observational multi-
center cohort study demonstrated, as did others, that RKF
had a direct and strong relationship to a decreased expected
mortality. On the other hand, excess ultrafiltration relative to
interdialytic weight gain, which they postulated was more
likely in those patients with high RKF, was an important
predictor of mortality, independent of dialysis clearance.
The forces driving the changes in the frequency of early
start of dialysis remain to be elucidated. It is possible that
KDOQI guideline development and promulgation and the
unrealized but postulated benefits of early start have
contributed to the trends favoring earlier start of dialysis
between 1996 and 2005. Based on the consideration detailed
above, it does not appear that an overall increase in
comorbidities present at the time dialysis is initiated can
fully explain these trends.
WHAT ARE THE POTENTIAL EFFECTS OF EARLY START ON
INCIDENCE AND COST OF DIALYSIS THERAPY?
The phenomenon of a ‘rising tide’ of early start of dialysis
(herein defined as an eGFR410 ml/min per 1.73 m2 at
initiation of dialysis) may have influenced the incidence of
newly treated patients and the cost of the Medicare-ESRD
program as well. Figure 1 demonstrates that most of the
increase in USRDS treatment incidence counts over the
period 1996–2005 occurred in early start dialysis patients.
According to an analysis of the 2006 USRDS annual data
report, the average costs per year for treating dialysis patients
over the age of 65 years was $71,000. Comparing 1996–2005
dialysis treatment incidence counts, for the over 65-year
cohort, with starting eGFR greater than 10 ml/min per
1.73 m2, there were 18,076 more patients started in 2005
versus 1996. If one assumes that half these new starts could
have been safely delayed, the annual additional costs could be
estimated to be approximately $641 million in 2006 alone.
It is not clear how many or indeed if any nephrologists use
a specific eGFR level as an arbitrary threshold as a sole
indication to start dialysis. Additional studies are needed to
evaluate this possibility. Patients with a higher eGFR at
dialysis initiation may well also have some of the other
accepted clinical indications for starting the dialysis. The
presence of uremic encephalopathy, uremic pericarditis,
diuretic-resistant volume overload with congestive heart
failure and perhaps progressive malnutrition (due to
anorexia) may be indications for starting dialysis, even if
eGFR is X10 or even 415 ml/min per 1.73 m2. However,
conservative management, especially in the elderly with
multiple comorbidities and at most 1–2 year life expectancies,
may be a better choice especially when considering quality of
life issues. Murtagh, et al.17, suggested that in patients with
significant comorbidity (ischemic heart disease, in particu-
lar), non-dialytic therapy provided by a nephrologist might
offer a comparable survival without the risks and quality of
life effects of dialysis treatment. The regular monitoring and
careful management of blood pressure, nutrition and
psychosocial well-being that attends dialysis therapy should
also be offered to these patients.
Regardless of its underlying mechanisms or effects, the
‘rising tide’ of an early start of dialysis is viewed with
concern, as it may not be justified on the basis of the risk/
benefit relationship. Efforts should be undertaken now to
study the phenomenon further with particular emphasis on
the stability of eGFR in CKD Stages 4 and 5. Specifically, a US
study of the impact of early versus late start of dialysis (using
eGFR as the discriminating variable) on morbidity, mortality,
and quality of life in the pre-and post- dialysis periods could
be undertaken. This study would differ from the IDEAL
protocol in that all subjects would be randomized at the early
start (relative to RKF) to thrice weekly dialysis or to thrice
weekly assessments and non-dialytic medical interventions to
balance the benefits of a thrice weekly health assessment in a
dialysis program.
SUMMARY AND CONCLUSIONS
A clear trend of initiating dialysis at higher levels of estimated
residual kidney function has been evident between 1996 and
2005. The reasons underlying this trend require further study.
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However, if this trend continues it will likely have adverse
financial implications. The basis for starting dialysis early
(eGFR over 10 ml/min/1.73 m2) may be fundamentally
flawed, because recent studies do not support a positive
relationship between dialysis clearance as an additive
contributor to a patient’s overall renal function and to
outcomes on dialysis treatment. Starting dialysis early might
result in a more rapid decline of a patient’s residual kidney
function. Residual kidney function has been shown to have a
positive relation to outcome.9,19 Until randomized controlled
trials are completed and with the possibility that, in some
cases, early start of dialysis therapy may be harmful, the
nephrology community needs to ‘first do no harm’, and only
offer early dialysis when a clear indication for such a strategy
exists.
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